Literature DB >> 16862502

[Whole-body MR diagnostic concepts].

S C Ladd1, M Zenge, G Antoch, M Forsting.   

Abstract

The term whole-body magnetic resonance imaging (MRI) covers a whole series of different MRI techniques that can be used for detecting various diseases. Whole-body magnetic resonance angiography facilitates the visualization of the entire arterial system from head to toe with the exception of the coronary arteries. Whole-body MRA is clinically used for therapy planning in patients with multiple stenoses and may be able to be used in the future as a screening method for high risk populations, for example in patients with coronary heart disease. Whole-body MRI can replace skeletal scintigraphy in the detection of bone marrow metastases by using fluid-sensitive sequences. Fast contrast-enhanced sequences can be used as an alternative approach in the search for tumors. Whole-body MRI can even be superior to a combination of positron-emission tomography and computed tomography in the detection of distant metastases. This article presents the recent developments in whole-body MRI and its established indications, which in the future might lead to a change in the paradigm for the diagnostic work-up of many diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16862502     DOI: 10.1055/s-2006-926914

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  4 in total

1.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

Review 2.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

3.  Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.

Authors:  G Cascini; C Falcone; C Greco; B Bertucci; S Cipullo; O Tamburrini
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

4.  Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.

Authors:  Dobromila Baranska; Katarzyna Matera; Michal Podgorski; Magdalena Gorska-Chrzastek; Karolina Krajewska; Joanna Trelinska; Piotr Grzelak
Journal:  MAGMA       Date:  2018-11-29       Impact factor: 2.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.